AIDS Weekly
Susan Hasty, Publisher
Table of Contents . . . May 9th, 2005
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly | Other Publications
HIV/AIDS Drug Development - High-throughput modified ELISA screens HIV-1 pg41 fusion inhibitors
HIV/AIDS Drug Development - Sulfonated naphthyl porphyrins active against HIV-1
HIV/AIDS Mental Health - Apathy correlates with cognitive function but not CD4 status in HIV infection
HIV/AIDS Pathogenesis - B30.2(SPRY) domain is the major determinant of anti-HIV-1 potency
HIV/AIDS Vaccine - Anti-HIV Abs induced to control viremia via complement-mediated inactivation
Bioterrorism - Construction company responds to airborne infectious disease isolation needs
Blood Safety - People's Republic of China signs pact with blood safety organization
Business & Finance - Life science company announces preliminary second quarter finances
Business Update - HIV/AIDS report features Hemopurifier developer
Diagnostics - Diagnostics company achieves ISO, Canadian regulatory certification
Drug Resistance - A new therapeutic strategy for HIV
Drug Safety - Contraindicated protease inhibitor/statin combinations still over-prescribed
Finance - Safety needle device announces financial results
HIV/AIDS - AIDS support group commends progress
HIV/AIDS Antenatal Screening - Characteristics of women in London who decline testing identified
HIV/AIDS Drug Development - HIV receptor site interactions with metallocyclams investigated
HIV/AIDS Drug Development - NNRTI derivatives more potent against HIV-1 than efavirenz
HIV/AIDS Drug Development - Trimeric membrane-anchored gp41 inhibits HIV membrane fusion
HIV/AIDS Pathogenesis - HIV-1 Nef reduces rate of recycling of transferrin receptor to plasma membrane
HIV/AIDS Pathogenesis - HIV-1 Tat stimulates TC assembly through TBP recruitment in absence of TAFs
HIV/AIDS Pathogenesis - HIV-1 Vpr binds to 14-3-3 proteins and facilitates complex formation with Cdc25C
HIV/AIDS Pathogenesis - HIV-1 causes cell death via HIV-1 Vpr derived C terminal peptide
HIV/AIDS Pathogenesis - Interleukin-7 increases HIV-1 LAI-mediated Fas-induced T-cell death
HIV/AIDS Pathogenesis - Preferential apoptosis of HIV-1-specific CD4+ cells in HIV-infected persons
HIV/AIDS Pathogenesis - SATBI interacts with Tat in HIV-1-infected T cells
HIV/AIDS Research - Research in HIV/AIDS provides new insights
HIV/AIDS Research - Tanzania HIV/AIDS Indicator Survey results reported
HIV/AIDS Testing - Contract awarded in Nigeria for HIV test kits
HIV/AIDS Therapy - HIV treatment-experienced patients set high standards for therapy success
HIV/AIDS Therapy - Micronucleated erythrocyte frequency in AZT-treated mice reported
HIV/AIDS Therapy - Mutations in HIV subtypes must be better understood to prevent resistance
HIV/AIDS Therapy - Study reveals candidate targets for antiretroviral therapeutics
HIV/AIDS Therapy - Testosterone replacement doesn't improve weight, muscle strength in HIV+ women
HIV/AIDS Therapy - The case for earlier treatment of HIV infection
HIV/AIDS Transmission - Breast milk-derived antigen-specific CD8+ T cells described
HIV/AIDS Vaccine - Immune responses maintain CTL epitope mutations in transmitted SIV
HIV/AIDS Vaccine - Long-term vaccine-mediated control of SHIV 89.6P challenge reported
HIV/AIDS Vaccines - Recent studies add new data to HIV/AIDS vaccines research
HIV/HPV Coinfection - Study examines natural history of HPV in HIV positive women
Hepatitis B Therapy - PEGASYS hepatitis B trials presented at liver disease conference
Hepatitis C Therapy - Health Canada grants approval for clinical trial in hepatitis C therapy
Infectious Diseases - Reports notes continued increase in sexually transmitted diseases in youth
Kaposi Sarcoma-Associated Herpesvirus - KSHV LANA protects lymphoid cells from p16 INK4A-induced cell cycle arrest
Opportunistic Infections - Guide for treating opportunistic infections in HIV+ people released
Product Licensing - Diagnostics company purchases property for detecting tick borne diseases
Public Health - IT management company expands efforts to automate public health laboratories
Simian Immunodeficiency Virus - Unliganded/fully glycosylated SIV gp120 structure determined
Vaccine Development - License application submitted for investigational vaccine for rotavirus
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
